Mode
Text Size
Log in / Sign up
Phase 3 N=152 Randomized Double-blind Prevention

Preoperative Single-dose Steroid Application for the Treatment of Nausea and Vomiting After Thyroid Surgery

Thyroidectomy · Thyroid Diseases

Enrolled (actual)
152
Serious AEs
0.0%
Results posted
Jul 2015
Primary outcome: Primary: Incidence of Postoperative Nausea and Vomiting — 29; 57 percentage of participants — p=0.001

Study Design & Population

Study type
Interventional
Phase
Phase 3
Interventions
Dexamethasone (Drug); NaCl 0.9% (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Cantonal Hospital of St. Gallen
Primary completion
May 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
Incidence of Postoperative Nausea and Vomiting
28; 52 0.006 sig
SECONDARY
Incidence of Postoperative Nausea and Vomiting
28; 52 0.006 sig
SECONDARY
Degree of Post Operative Nausea and Vomiting
5; 7; 0; 3; 8; 12
SECONDARY
Degree of Post Operative Nausea and Vomiting
5; 7; 0; 3; 8; 12
SECONDARY
Postoperative Pain After Physical Stress
1.88; 2.09; 1.88; 2.01 0.674
SECONDARY
Length of Hospital Stay
48.3; 48.1 0.835
SECONDARY
Necessary Anesthesiological Medication
1097; 1168; 1.944; 1.978; 0.427; 0.444

Summary

The study is to compare the postoperative recovery, as determined by postoperative nausea and vomiting (PONV) after preoperative application of single-dose dexamethasone versus saline in patients undergoing partial or total thyroidectomy.

Eligibility Criteria

Inclusion Criteria

  • Age > 18
  • Planned partial or total thyroidectomy

Exclusion Criteria

  • History of adverse effects to dexamethasone or propyleneglycol or di-natrium-EDTA
  • Patients with chronic pain
  • Necessity for opioids-application in the postoperative course
  • Not possible administration of a cervical block (0.5% bupivacaine at a dose of 20ml)
  • Patients with Diabetes mellitus
  • Pregnancy (test in young women)
  • Glaucoma
  • Patients who received antiemetic therapy within 48h before surgery
  • Patients with acute pain requiring painkillers others than paracetamol or more than single dose NSAR treatment within 48h before surgery
  • Use of psychotropic drugs
  • Incompliant patients
  • Preoperatively high suspicion of malignancy
  • Re-operations
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01189292). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search